Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Actual shortage | 2025-10-10 | 2026-01-22 | 269226 |
| TEVA-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-03 | 223838 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-03-10 | 2022-05-19 | 156410 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2024-05-16 | 2025-08-21 | 228149 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2020-04-23 | 2020-05-21 | 113028 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-02-16 | 2023-08-04 | 184931 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-01-27 | 2022-02-25 | 153742 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-12-01 | 2022-12-15 | 176788 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-06-19 | 2023-07-05 | 195563 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-12-07 | 2024-03-21 | 212730 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-01-07 | 2021-02-05 | 131066 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-11-16 | 2023-11-23 | 210431 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-07-22 | 2021-09-30 | 142902 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 2MG 0.035MG | TABLET | Resolved | 2020-04-10 | 2020-05-29 | 111857 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2019-06-27 | 2019-08-24 | 87696 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2021-04-29 | 2021-09-02 | 138297 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2023-06-08 | 2023-06-21 | 194128 |
| TEVA-DASATINIB | 80MG | TABLET | Actual shortage | 2025-05-08 | 2025-10-10 | 256929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2019-10-17 | 2019-10-26 | 96730 |
| TEVA-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-08-08 | 2025-08-08 | 264816 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREGABALIN | 25MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258631 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258627 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258622 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-PREGABALIN | 300MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258756 |
| TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
| TEVA-PROFEN | 600MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258499 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Reversed | 2025-05-28 | 2025-06-20 | 258574 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 |